Alzheimer’s disease and Dementia

<span style="&quot;font-size:" 10pt;="" color:="" rgb(51,="" 51,="" 51);="" background-image:="" initial;="" background-position:="" background-size:="" background-repeat:="" background-attachment:="" background-origin:="" background-clip:="" initial;"="">Alzheimer's disease is a neurological cerebrum issue. Alzheimer's is the most widely recognized type of dementia. Dementia is a disorder, generally of a chronic or progressive nature, caused by a brain illness that affects memory, thinking, behavior and capability to perform regular exercises. The number of individuals living with dementia worldwide is at present evaluated at 47 million and is anticipated to increment to 75 million by 2030. The number of instances of dementia is assessed to relatively triple by 2050.

 

  • Alzheimer Disease and Cellular Mechanisms
  • Clinical Trials and Case Reports in Dementia
  • Dementia Care and Awareness
  • Drug Development in Dementia
  • Types of Dementia

Related Conference of Alzheimer’s disease and Dementia

September 21-22, 2020

14th International Conference on Genomics & Pharmacogenomics

Vancouver, Canada
September 23-24, 2020

24th European Biotechnology Congress

Berlin, Germany
October 19-20, 2020

7th Asia Pacific Geriatrics and Gerontology Congress

Tokyo, Japan
October 23-24, 2020

2nd International Conference on Biomarkers and Cancer Targets

Cape Town, South Africa
November 16-17, 2020

International Conference on Genomics and Molecular Biology

Lisbon, Portugal
November 19-20, 2020

24th European Biotechnology Congress (EBC_2020)

London, UK
November 23-24, 2020

International Conference on Toxicogenomics

Bali, Indonesia
December 07-08, 2020

2nd World Congress on Cell and Structural Biology

Sydney, Australia

Alzheimer’s disease and Dementia Conference Speakers

Recommended Sessions

Related Journals

Are you interested in